The Treatabolome, an emerging concept.
作者信息
Bonne Gisèle
机构信息
Sorbonne Université, Inserm, Institut de Myologie, Centre de Recherche en Myologie, F-75013 Paris, France. E-mail:
出版信息
J Neuromuscul Dis. 2021;8(3):337-339. doi: 10.3233/JND-219003.
Abstract
摘要
相似文献
1
The Treatabolome, an emerging concept.治疗代谢组，一个新兴概念。
J Neuromuscul Dis. 2021;8(3):337-339. doi: 10.3233/JND-219003.
2
[From the first french Telethon to the rare diseases act: the role of AFM].[从第一届法国电视募捐活动到罕见病法案：法国肌肉萎缩症协会（AFM）的作用]
Arch Pediatr. 2010 Jun;17(6):699. doi: 10.1016/S0929-693X(10)70066-X.
3
[Rare diseases health plan: outcome and expectations].[罕见病健康计划：成果与期望]
Arch Pediatr. 2010 Jun;17(6):700-1. doi: 10.1016/S0929-693X(10)70067-1.
4
Multidisciplinary management and care in rare neuromuscular disorders: A call for action.罕见神经肌肉疾病的多学科管理与照护：行动呼吁。
Eur J Neurol. 2024 Jun;31(6):e16265. doi: 10.1111/ene.16265. Epub 2024 Feb 29.
5
[Neuromuscular diseases are many but rare].神经肌肉疾病种类繁多但较为罕见。
Lakartidningen. 2013;110(15):752-3.
6
[Together for patients with hereditary neuromuscular conditions].[携手关爱遗传性神经肌肉疾病患者]
Tidsskr Nor Laegeforen. 2016 Aug 23;136(14-15):1198-9. doi: 10.4045/tidsskr.16.0502. eCollection 2016 Aug.
7
[The telethon and the promises not kept by gene therapy].[电视马拉松募捐活动与基因治疗未兑现的承诺]
Rev Med Suisse. 2013 Dec 18;9(411):2402-3.
8
The predictive value of models of neuromuscular disorders to potentiate clinical translation.神经肌肉疾病模型对促进临床转化的预测价值。
Dis Model Mech. 2022 Jul 1;15(7). doi: 10.1242/dmm.049788. Epub 2022 Aug 1.
9
Neuromuscular diseases: therapeutic advances.神经肌肉疾病：治疗进展
Lancet Neurol. 2008 Jan;7(1):12-4. doi: 10.1016/S1474-4422(07)70304-6.
10
[Neuromuscular diseases].[神经肌肉疾病]
Nervenarzt. 2011 Jun;82(6):695-6. doi: 10.1007/s00115-010-3038-0.
引用本文的文献
1
Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.对泛欧洲罕见病资源进行基因组重新分析得出了新的诊断结果。
Nat Med. 2025 Feb;31(2):478-489. doi: 10.1038/s41591-024-03420-w. Epub 2025 Jan 17.
2
The Metabolic Treatabolome and Inborn Errors of Metabolism Knowledgebase therapy tool: Do not miss the opportunity to treat!代谢治疗代谢组学与先天性代谢缺陷知识库治疗工具：不要错过治疗机会！
J Inherit Metab Dis. 2025 Jan;48(1):e12835. doi: 10.1002/jimd.12835.
3
The triple code model for advancing research in rare and undiagnosed diseases beyond the base pairs.超越碱基对推进罕见病和未确诊疾病研究的三联码模型。
Epigenomics. 2025 Feb;17(2):115-124. doi: 10.1080/17501911.2024.2436837. Epub 2024 Dec 4.
4
Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases.一个都不能少！诊断罕见病的创新技术应用专家建议。
Orphanet J Rare Dis. 2024 Sep 27;19(1):357. doi: 10.1186/s13023-024-03361-0.
5
Advancing diagnosis and research for rare genetic diseases in Indigenous peoples.推进原住民罕见遗传病的诊断和研究。
Nat Genet. 2024 Feb;56(2):189-193. doi: 10.1038/s41588-023-01642-1.
6
The Medical Action Ontology: A tool for annotating and analyzing treatments and clinical management of human disease.医学行动本体论：一种用于注释和分析人类疾病治疗与临床管理的工具。
Med. 2023 Dec 8;4(12):913-927.e3. doi: 10.1016/j.medj.2023.10.003. Epub 2023 Nov 13.
7
Resources and tools for rare disease variant interpretation.罕见病变异解读的资源与工具。
Front Mol Biosci. 2023 May 10;10:1169109. doi: 10.3389/fmolb.2023.1169109. eCollection 2023.
8
[Rare-disease data standards].[罕见病数据标准]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Nov;65(11):1126-1132. doi: 10.1007/s00103-022-03591-2. Epub 2022 Sep 23.
9
Genetic pain loss disorders.遗传性疼痛缺失障碍。
Nat Rev Dis Primers. 2022 Jun 16;8(1):41. doi: 10.1038/s41572-022-00365-7.
10
How to proceed after "negative" exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques.“阴性”外显子组之后如何进行：遗传诊断、局限性、挑战以及新兴的多组学技术综述。
J Inherit Metab Dis. 2022 Jul;45(4):663-681. doi: 10.1002/jimd.12507. Epub 2022 May 22.
本文引用的文献
1
A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.罕见病治疗系统评价撰写指南，以生成符合 FAIR 原则的数据集合：构建 Treatabolome。
Orphanet J Rare Dis. 2020 Aug 12;15(1):206. doi: 10.1186/s13023-020-01493-7.
2
Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome.先天性肌无力综合征的靶向治疗：系统评价及迈向可治疗组学的步骤
Emerg Top Life Sci. 2019 Mar;3(1):19-37. doi: 10.1042/ETLS20180100. Epub 2019 Jan 28.
3
Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.2017 - 2027年罕见病研究的未来：国际罕见病研究协作网观点
Clin Transl Sci. 2018 Jan;11(1):21-27. doi: 10.1111/cts.12500. Epub 2017 Oct 23.
4
Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.2010 - 2016年罕见病研究进展：国际罕见病研究协作网视角
Clin Transl Sci. 2018 Jan;11(1):11-20. doi: 10.1111/cts.12501. Epub 2017 Oct 23.
5
The FAIR Guiding Principles for scientific data management and stewardship.科学数据管理和保存的 FAIR 指导原则。
Sci Data. 2016 Mar 15;3:160018. doi: 10.1038/sdata.2016.18.
Zotero 插件